← Back to Patent Explorer
US5736336A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility

Assignee: Individual
•
Filing: 1997-05-01
•
Granted: 1998-04-07
•
Expires: 2017-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than a corresponding DNA strand, and exhibit increased sequence specificity and solubility. The peptide nucleic acids comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone, and contain C 1 -C 8 alkylamine side chains. Methods of enhancing the solubility, binding affinity and sequence specificity of PNAs are provided.

Inventors

  • 👤 Ole Buchardt, deceased
  • 👤 representative by Dorte Buchardt
  • 👤 Michael Egholm
  • 👤 Peter Eigil Nielsen
  • 👤 Rolf Henrik Berg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 13:35
CPC Classifications
C; C07; C07H; C07H21/00; C07K; C07K14/00; C07K14/001; C07K14/003; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06017; C07K5/06026; C07K5/06139; C07K7/00; C07K7/04; C07K7/06; C07K7/08; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6869; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S435/00; Y10S435/81

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 100 words
A method for enhancing the DNA or RNA sequence specificity of a peptide nucleic acid by incorporating C 1 -C 8 akylamine side chain in said peptide nucleic acid having formula: ##STR3## wherein each L is independently selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases; each R 7' is independently hydrogen or C 1 -C 8 alkylamine, provided that at least one R 7' is C 1 -C 8 alkylamine; R h is OH, NH 2 or NHLysNH 2 ; R i is H, COCH 3 or t-butoxycarbonyl; and n is an integer from 1 to 30.
Claim 2
Independent Claim 100 words
A method for enhancing the DNA or RNA sequence specificity of a peptide nucleic acid by incorporating C 1 -C 8 akylamine side chain in said peptide nucleic acid having formula: ##STR3## wherein each L is independently selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases; each R 7' is independently hydrogen or C 1 -C 8 alkylamine, provided that at least one R 7' is C 1 -C 8 alkylamine; R h is OH, NH 2 or NHLysNH 2 ; R i is H, COCH 3 or t-butoxycarbonyl; and n is an integer from 1 to 30.
Claim 3
Dependent Claim 19 words
The method of claim 1 wherein at least one of said R 7' is C 3 -C 6 alkylamine.
Claim 4
Dependent Claim 17 words
The method of claim 2 wherein at least one R 7' is C 4 -C 5 alkylamine.
Claim 5
Dependent Claim 13 words
The method of claim 3 wherein at least one R 7' is butylamine.
Claim 6
Dependent Claim 14 words
The method of claim 4 wherein substantially all of the R 7' are butylamine.
Claim 7
Dependent Claim 24 words
The method of claim 1 wherein at least one of the carbon atom to which the substituent R 7' is attached is stereochemically enriched.
Claim 8
Dependent Claim 14 words
The method of claim 6 wherein said stereochemical enrichment is of the R configuration.
Claim 9
Dependent Claim 14 words
The method of claim 7 wherein substantially all of the R 7' are butylamine.
Claim 10
Dependent Claim 16 words
The method of claim 1 wherein said peptide nucleic acid is derived from an amino acid.
Claim 11
Dependent Claim 14 words
The method of claim 9 wherein said peptide nucleic acid is derived from D-lysine.
Claim 12
Independent Claim 101 words
A method for enhancing the DNA or RNA binding affinity of a peptide nucleic acid by incorporating C 1 -C 8 alkylamine side chain in said peptide nucleic acid having the formula: ##STR4## wherein: each L is independently selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases; each R 7' is independently hydrogen or C 1 -C 8 alkylamine, provided that at least one R 7' is C 1 -C 8 alkylamine; R h is OH, NH 2 or NHLysNH 2 ; R i is H, COCH 3 or t-butoxycarbonyl; and n is an integer from 1 to 30.
Claim 13
Independent Claim 101 words
A method for enhancing the DNA or RNA binding affinity of a peptide nucleic acid by incorporating C 1 -C 8 alkylamine side chain in said peptide nucleic acid having the formula: ##STR4## wherein: each L is independently selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases; each R 7' is independently hydrogen or C 1 -C 8 alkylamine, provided that at least one R 7' is C 1 -C 8 alkylamine; R h is OH, NH 2 or NHLysNH 2 ; R i is H, COCH 3 or t-butoxycarbonyl; and n is an integer from 1 to 30.
Claim 14
Dependent Claim 19 words
The method of claim 11 wherein at least one of said R 7' is C 3 -C 6 alkylamine.
Claim 15
Dependent Claim 17 words
The method of claim 12 wherein at least one R 7' is C 4 -C 5 alkylamine.
Claim 16
Dependent Claim 13 words
The method of claim 13 wherein at least one R 7' is butylamine.
Claim 17
Dependent Claim 14 words
The method of claim 14 wherein substantially all of the R 7' are butylamine.
Claim 18
Dependent Claim 24 words
The method of claim 11 wherein at least one of the carbon atom to which the substituent R 7' is attached is stereochemically enriched.
Claim 19
Dependent Claim 14 words
The method of claim 16 wherein said stereochemical enrichment is of the R configuration.
Claim 20
Dependent Claim 14 words
The method of claim 17 wherein substantially all of the R 7' are butylamine.
Claim 21
Dependent Claim 16 words
The method of claim 11 wherein said peptide nucleic acid is derived from an amino acid.
Claim 22
Dependent Claim 14 words
The method of claim 19 wherein said peptide nucleic acid is derived from D-lysine.

References Cited (Backward Citations)

WO1986005518A1 Cited
US5034506A Cited
WO1990002749A1 Cited
US5166315A Cited
WO1992020702A1 Cited
US5340716A Cited
WO1994006815A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-04-06 2001-10-06 2002-04-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-04-06 2005-10-06 2006-04-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-04-06 2009-10-06 2010-04-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag